Press Release
CGT Global Welcomes Dr. Jerome Ritz to Its Board of Advisors, Enriching Knowledge of Cellular Therapies and Hematology
By:CGT GlobalviaBusiness Wire August 14, 2025 at 09:00 AM EDT CGT Global, a biotechnology leader accelerating access to life-changing cell and gene therapies, today announced the appointment of Jerome Ritz, MD, to its Board of Advisors. Dr. Ritz brings a distinguished career in hematology, oncology, cell manufacturing, and the advancement of cell and gene therapies.…
For More InformationCGT Global Appoints Dr. Andrew Branagan to Board of Advisors, Expanding Cell and Gene Therapy Expertise
CGT Global, a leading biotechnology company driving the development and delivery of innovative cell and gene therapies, today announced the appointment of Andrew Robert Branagan, MD, PhD, to its Board of Advisors. Dr. Branagan brings extensive expertise in hematologic malignancies, immunology, and the development of novel therapeutic strategies, including cellular therapies. This press release features…
For More InformationMeet CGT Global’s Scientific Team: Bryan Pulling – Laboratory Operations Manager
Written by Joanna Wirkus, PhD Every day at CGT Global, our experienced team collaborates to deliver high quality cells to scientists around the world. Success starts with the strength of our team and the dedication of the people who power it. In this edition of Meet the Scientific Team, we’re proud to spotlight Bryan Pulling…
For More InformationEIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States
FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global…
For More InformationPartnership Newsflash
CGT GLOBAL SELECTED AS STRATEGIC PARTNER TO EXPAND CELL AND GENE THERAPIES ACROSS THE UNITED STATES CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has cell and gene therapy mobile laboratories currently…
For More Information